News & Updates

Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC

21 May 2023

In the third-line treatment of patients with refractory RAS wild-type metastatic colorectal cancer (MCRC), use of panitumumab plus the standard-of-care trifluridine-tipiracil appears to prolong progression-free survival (PFS) when compared with trifluridine-tipiracil alone, according to data from a phase II study.

Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC

21 May 2023

Olive oil, emulsified fat tied to better carotenoid absorption

21 May 2023

A recent study has demonstrated the importance of both the type and the emulsification of dietary fat to carotenoid absorption.

Olive oil, emulsified fat tied to better carotenoid absorption

21 May 2023

Herbal combination works in treatment of active ulcerative colitis

20 May 2023

The herbal combination of curcumin plus QingDai (CurQD) appears beneficial to patients with active ulcerative colitis (UC), with a recent study showing that the combination induced clinical and biomarker remission.

Herbal combination works in treatment of active ulcerative colitis

20 May 2023

Broad-spectrum antibiotic exposure ups risk of IBD

20 May 2023

Exposure to broad-spectrum antibiotics may put individuals at risk of developing inflammatory bowel disease (IBD), such that the greater the dose, the higher the risk, as shown in a study.

Broad-spectrum antibiotic exposure ups risk of IBD

20 May 2023

Digital gut-directed hypnotherapy reduces abdominal pain in IBS patients

20 May 2023 by

Digital gut-directed hypnotherapy (GDH) programme reduces abdominal pain in adults with irritable bowel syndrome (IBS) compared with digital muscle relaxation (MR), according to a study presented at DDW 2023.

Digital gut-directed hypnotherapy reduces abdominal pain in IBS patients

20 May 2023

Smoking, asthma tied to worse faecal incontinence symptoms

19 May 2023 by

More severe faecal incontinence symptoms appear to burden tobacco smokers, reveals a recent study presented at DDW 2023. Tobacco use is also associated with weaker anal sphincter tone and increased rectal hypersensitivity on high-resolution anorectal manometry (HRAM).

Smoking, asthma tied to worse faecal incontinence symptoms

19 May 2023

Is dexmedetomidine the perfect adjuvant drug to propofol?

17 May 2023

Use of dexmedetomidine has lessened the effective concentration (EC50) of propofol administered via plasma target-controlled infusion (TCI) during gastrointestinal endoscopy, a study has found. A 0.5‒1 μg/kg dose of dexmedetomidine results in a lower heart rate (HR) without bradycardia.

Is dexmedetomidine the perfect adjuvant drug to propofol?

17 May 2023

Guselkumab safe, effective as induction therapy for UC

17 May 2023 by

Induction therapy with guselkumab, an interleukin-23 p19 subunit antagonist, results in clinical and symptomatic remission, as well as other endoscopic improvements in patients with moderate-to-severe active ulcerative colitis (UC), according to the QUASAR study presented at DDW 2023.

Guselkumab safe, effective as induction therapy for UC

17 May 2023

Histologic remission predicts relapse-free survival in ulcerative colitis

15 May 2023

Histologic remission using the validated Nancy histologic index (NHI) score is independently associated with a significantly longer relapse-free survival and appears to be a better therapeutic target than endoscopic remission in patients with ulcerative colitis (UC), reports a study.

Histologic remission predicts relapse-free survival in ulcerative colitis

15 May 2023

SBRT effective, well tolerated for unresectable liver metastases

15 May 2023 by

A retrospective study in Hong Kong has shown that stereotactic body radiotherapy (SBRT) is an effective and well-tolerated treatment for patients with unresectable liver metastases.

SBRT effective, well tolerated for unresectable liver metastases

15 May 2023

News & Updates

Filter by Specialty:

Specialty:

Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC

Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC

Olive oil, emulsified fat tied to better carotenoid absorption

Olive oil, emulsified fat tied to better carotenoid absorption

Herbal combination works in treatment of active ulcerative colitis

Herbal combination works in treatment of active ulcerative colitis

Broad-spectrum antibiotic exposure ups risk of IBD

Broad-spectrum antibiotic exposure ups risk of IBD

Digital gut-directed hypnotherapy reduces abdominal pain in IBS patients

Digital gut-directed hypnotherapy reduces abdominal pain in IBS patients

Smoking, asthma tied to worse faecal incontinence symptoms

Smoking, asthma tied to worse faecal incontinence symptoms

Is dexmedetomidine the perfect adjuvant drug to propofol?

Is dexmedetomidine the perfect adjuvant drug to propofol?

Guselkumab safe, effective as induction therapy for UC

Guselkumab safe, effective as induction therapy for UC

Histologic remission predicts relapse-free survival in ulcerative colitis

Histologic remission predicts relapse-free survival in ulcerative colitis

SBRT effective, well tolerated for unresectable liver metastases

SBRT effective, well tolerated for unresectable liver metastases